Myelodysplastic syndrome: MDS
4th International Conference on Blood Malignancies & Treatment
April 18-19, 2016 Dubai, UAE

Ahmad Ali Basha

Saudi German Hospital, Dubai

Posters & Accepted Abstracts: J Blood Disord Transfus

Abstract:

Myelodysplastic syndromes (MDS) are a spectrum of clonal myeloid disorders characterized by ineffective hematopoiesis, cytopenias, qualitative disorders of blood cells, clonal chromosomal abnormalities, and the potential for clonal evolution to acute myeloid leukemia (AML). In this review, we discuss the various pathogenic conditions included in the spectrum of MDS and the associated risk stratification for these conditions. We further discuss the treatment recommendations based on the risk status and the expected prognosis.

Biography :

Email: alipash@yandex.ru